CJC-1295 (without DAC) and MENT Interaction

Synergistic
Mechanism-based 49% confidence

CJC-1295 (without DAC) and MENT have a synergistic interaction with 49% confidence. MENT helps manage estrogen conversion from CJC-1295 (without DAC). This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

MENT

19-Nor Anabolic Steroid | Experimental TRT Alternative

MENT binds to the androgen receptor with high affinity, estimated at roughly 10 times the potency of testosterone, driving robust activation of AR-dependent gene transcription pathways responsible for protein synthesis, nitrogen retention, and satellite cell proliferation in skeletal muscle. Its 7-alpha methyl group renders it resistant to 5-alpha reductase, meaning it is not converted to a reduced metabolite in androgen-sensitive tissues the way testosterone is converted to DHT or nandrolone is converted to DHN.

Half-life: ~40 minutes (acetate ester) Typical dose: 5-25 mg/day (acetate) anabolic, sexual health
5 alpha reductaseandrogen receptorepo receptorestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
GI Tract
low
Pituitary
low
Liver
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), MENT). Monitor accordingly.
2x 2 estrogenic compounds (CJC-1295 (without DAC), MENT). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), MENT). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with MENT?

Yes, CJC-1295 (without DAC) and MENT can generally be taken together. MENT helps manage estrogen conversion from CJC-1295 (without DAC). This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is CJC-1295 (without DAC) and MENT safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, estrogenic, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and MENT?

MENT helps manage estrogen conversion from CJC-1295 (without DAC). This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 49% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and MENT?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and MENT has a half-life of ~40 minutes (acetate ester). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs MENT

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.